Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease

John W. Singleton*, Stephen Hanauer, Malcolm Robinson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences